Literature DB >> 18922528

Atherosclerosis progression affects the relationship between endothelial function and aortic stiffness.

Grzegorz Kopeć1, Piotr Podolec, Jakub Podolec, Paweł Rubiś, Krzysztof Zmudka, Wiesława Tracz.   

Abstract

Aortic stiffening is the most important determinant of elevated systolic blood pressure which in turn is the main contributor to the burden of disease attributable to hypertension. Endothelial function may affect arterial stiffening as has been shown for carotid-aorto-femoral segments in healthy humans or subjects with cardiovascular risk factors. We investigated whether this association is present selectively for aorta and whether it extends to patients with advanced atherosclerosis. Direct measurements of aortic pulse wave velocity (aPWV) to assess aortic stiffness and brachial artery flow-mediated dilatation (bFMD) tests to assess endothelial function were performed in 111 consecutive patients suspected of coronary artery disease. Progression of atherosclerosis was determined on the basis of the presence or absence of significant coronary artery stenosis, CAS (>or=50%) in angiography. bFMD was lower (P<0.001) and aPWV was higher (P<0.001) in a group of 72 patients with advanced atherosclerosis when compared with a group of 39 patients without significant CAS. bFMD was inversely associated with aPWV but only in patients without advanced atherosclerosis (r=-0.37, P=0.02), even after adjustment of confounding factors in a multivariate analysis model (R(2)=0.37, P<0.001). We concluded that endothelial function may influence aortic stiffness which is limited however by the progression of atherosclerosis.

Entities:  

Mesh:

Year:  2008        PMID: 18922528     DOI: 10.1016/j.atherosclerosis.2008.09.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction.

Authors:  R M Bruno; G Penno; G Daniele; L Pucci; D Lucchesi; F Stea; L Landini; G Cartoni; S Taddei; L Ghiadoni; S Del Prato
Journal:  Diabetologia       Date:  2012-03-13       Impact factor: 10.122

2.  Chemokine RANTES is increased at early stages of coronary artery disease.

Authors:  J Podolec; G Kopec; L Niewiara; M Komar; B Guzik; K Bartus; L Tomkiewicz-Pajak; T J Guzik; W Plazak; K Zmudka
Journal:  J Physiol Pharmacol       Date:  2016-04       Impact factor: 3.011

3.  Arterial stiffness in adult patients after Fontan procedure.

Authors:  Lidia Tomkiewicz-Pajak; Hanna Dziedzic-Oleksy; Jacek Pajak; Maria Olszowska; Jacek Kolcz; Monika Komar; Piotr Podolec
Journal:  Cardiovasc Ultrasound       Date:  2014-04-10       Impact factor: 2.062

4.  Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.

Authors:  Grzegorz Kopeć; Marcin Waligóra; Anna Tyrka; Kamil Jonas; Michael J Pencina; Tomasz Zdrojewski; Deddo Moertl; Jakub Stokwiszewski; Paweł Zagożdżon; Piotr Podolec
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

5.  Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension.

Authors:  Kamil Jonas; Marcin Waligóra; Wojciech Magoń; Tomasz Zdrojewski; Jakub Stokwiszewski; Wojciech Płazak; Piotr Podolec; Grzegorz Kopeć
Journal:  Arch Med Sci       Date:  2018-10-25       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.